A new dad in Edmonton is calling the expansion of a treatment for newborns a “beautiful thing.” Devon Bedard and his wife welcomed their first child recently and were some of the first parents to take advantage of new publicly funded respiratory syncytial virus (RSV) antibodies for newborns. “It’s a very special thing that they’re doing,” Bedard said. “We felt very comforted in the process to proceed forward with this option for our son.” Until March 31, all babies born in Alberta hospitals will be eligible to receive the treatment that was previously only covered for infants deemed “high risk.” The antibody injection is up to 80 per cent effective in preventing RSV in infants, said Shannon Anderson, a clinical nurse specialist with the Women’s and Child Health Program for Covenant Health. “It is a bodyguard. It attaches itself to the virus and stops it,” Anderson said. “RSV prevention will keep your baby out of the hospital,” she added. “This will keep families out of our emergency rooms and keep them at home safe.” RSV is a respiratory virus spread through coughing, sneezing and touching contaminated surfaces. According to the Government of Canada, almost all children have contracted it by two years old. The younger the child, the higher the risk of severe outcomes. Alberta’s 2025-2026 RSV season, which peaked in the winter months, saw 549 babies hospitalized with the virus, with 66 of them needing the intensive care unit (ICU). Infectious diseases expert Craig Jenne, a professor and deputy director of the Snyder Institute at the University of Calgary, said there is an RSV vaccine but that babies can’t get it. “This is an immunization where we give the babies pre-made antibodies, and they basically get an instant immune system that will last them through the respiratory virus season,” Jenne said. He added that the medical community has long been advocating for better access to combat the high number of babies ending up in ICUs. “Other provinces have offered this to infants for a couple respiratory virus seasons now, and Alberta really was dragging behind,” Jenne said. “Parents were left with a tough choice whether they could afford to pay,” he continued. “Seeing this openly accessible means that we don’t have to choose.” Anderson said the one-time injection will only be available in the hospital when a baby is born and she hopes families will take advantage of the new program. Bedard said the nurses and doctors are good resources to answer questions and put parents’ minds at ease. “You want to do the best thing for your child,” he said. “As our nurse or our doctor said beforehand, it’s been around for a while. It’s a safe option, and it prevents our kids from spending more time in the hospitals … giving us a safe, healthy beginning.” Since August this year, 10 infants under one year old have been hospitalized with RSV, including two that needed to be admitted to the ICU. Another five children between the age of one and five went to hospital, though none to the ICU. RSV can also have more serious outcomes for older people. All of the 67 people who died from RSV during the last respiratory virus season were above 40. The only death so far this year was a person in their 80s. The 2025-2026 year had a total of 5,086 confirmed RSV cases; 1,930 people were hospitalized and 166 went to the ICU. The RSV shots have been available in Canada since 2023. Publicly funded shots for all newborns were rolled out on Nov. 1. More information can be found on the Government of Alberta website.